Pancreatic cancer mRNA vaccine shows lasting results in an early trial

An early trial of an mRNA vaccine for pancreatic cancer showed promising results, with half of the patients responding to the treatment. The vaccine appears to stimulate the immune system to attack cancer cells, potentially offering a new approach to treating this aggressive form of cancer.